Safety and Performance Study of the Nyxoah SAT System for Treating OSA

Safety and Performance Study of the Use of the Nyxoah SAT System for the Treatment of Obstructive Sleep Apnea

A prospective open-label, single treatment study to assess the safety and the performance of the Nyxoah SAT system for the treatment of Obstructive Sleep Apnea

Inclusion Criteria:

• Diagnosed with moderate to severe Obstructive Sleep Apnea
• Have failed or have not tolerated CPAP treatment
• Willing and capable of providing informed consent
• Willing and capable of returning to all follow-up visits and sleep studies, including evaluation procedures and filling out questionnaires

Exclusion Criteria:

• BMI limits
• Subjects with complete concentric collapse at the soft palate level per endoscopy